Dioxopromethazine

• UNSPSC Description:

  Dioxopromethazine is an orally active antihistamine. Dioxopromethazine inhibits asthmatic symptoms[1].

• Target Antigen:

  Histamine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Immunology/Inflammation;Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/dioxopromethazine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN(C)C(C)CN1C2=C(C=CC=C2)S(C3=CC=CC=C13)(=O)=O

• Molecular Weight:

  316.42

• References & Citations:

  [1]Bartsch R, et al. Zur Pharmakologie des neuen Antihistaminicums 9.9-Dioxopromethazin (Prothanon) [Pharmacology of the new antihistaminic 9,9-dioxopromethazine (Prothanon)]. Pharmazie. 1970;25(2):91-96.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  13754-56-8